Predicting PARP inhibitor sensitivity and resistance

被引：4
|
作者：
Bebb, D. Gwyn [1 ,2 ]
Lees-Miller, Susan P. [2 ,3 ,4 ]
机构：
[1] Tom Baker Canc Clin, Div Med Oncol, Calgary, AB, Canada
[2] So Alberta Canc Res Inst, Calgary, AB, Canada
[3] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada
[4] Univ Calgary, Dept Oncol, Calgary, AB, Canada
来源：
CELL CYCLE | 2012年 / 11卷 / 22期
关键词：
HOMOLOGOUS RECOMBINATION; CELLS; ATM; DEFICIENCY;
D O I：
10.4161/cc.22604
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：4110 / 4110
页数：1
相关论文
共 50 条
  • [31] Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
    Oplustilova, Lenka
    Wolanin, Kamila
    Mistrik, Martin
    Korinkova, Gabriela
    Simkova, Dana
    Bouchal, Jan
    Lenobel, Rene
    Bartkova, Jirina
    Lau, Alan
    O'Connor, Mark J.
    Lukas, Jiri
    Bartek, Jiri
    [J]. CELL CYCLE, 2012, 11 (20) : 3837 - 3850
  • [32] Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers
    Lombardi, Anne J.
    Hoskins, Elizabeth E.
    Foglesong, Grant D.
    Wikenheiser-Brokamp, Kathryn A.
    Wiesmueller, Lisa
    Hanenberg, Helmut
    Andreassen, Paul R.
    Jacobs, Allison J.
    Olson, Susan B.
    Keeble, Winifred W.
    Hays, Laura E.
    Wells, Susanne I.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (08) : 1962 - 1972
  • [33] The tip of the iceberg: predicting PARP inhibitor efficacy in prostate cancer
    Gillessen, Silke
    Bristow, Robert G.
    [J]. LANCET ONCOLOGY, 2020, 21 (01): : 17 - 19
  • [34] PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian Cancer
    D'Andrea, Alan
    [J]. ONCOLOGIST, 2017, 22 : S1 - S1
  • [35] TARGETING WNT SIGNALING TO OVERCOME PARP INHIBITOR RESISTANCE
    Yamamoto, Tomomi M.
    McMellen, Alexandra
    Watson, Zachary L.
    Aguilera, Jennifer
    Sikora, Matthew J.
    Ferguson, Rebecca
    Numammadov, Elmar
    Moldovan, George-Lucian
    Thakar, Tanay
    Kim, Hyunmin
    Cittelly, Diana M.
    Wilson, Heidi
    Behbakht, Kian
    Bitler, Benjamin G.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 104 - 104
  • [36] Role of Akt Activation in PARP Inhibitor Resistance in Cancer
    Gallyas, Ferenc, Jr.
    Sumegi, Balazs
    Szabo, Csaba
    [J]. CANCERS, 2020, 12 (03)
  • [37] Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
    Soung, Young-Hwa
    Chung, Jun
    [J]. BIOMOLECULES, 2023, 13 (10)
  • [38] PARP inhibitor resistance: the underlying mechanisms and clinical implications
    He Li
    Zhao-Yi Liu
    Nayiyuan Wu
    Yong-Chang Chen
    Quan Cheng
    Jing Wang
    [J]. Molecular Cancer, 19
  • [39] Mechanism of PARP inhibitor resistance and potential overcoming strategies
    Fu, Xiaoyu
    Li, Ping
    Zhou, Qi
    He, Ruyuan
    Wang, Guannan
    Zhu, Shiya
    Bagheri, Amir
    Kupfer, Gary
    Pei, Huadong
    Li, Juanjuan
    [J]. GENES & DISEASES, 2024, 11 (01) : 306 - 320
  • [40] Diverse mechanisms of PARP inhibitor resistance in ovarian cancer
    Wakefield, Matthew John
    Nesic, Ksenija
    Kondrashova, Olga
    Scott, Clare L.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1872 (02):
12345